ArticleAmerican journal of translational research2025
Clinicopathologic significance of FUT8, STX4, and calpain2 expression in ovarian cancer.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Single-cell transcriptomics uncovers heterogenous cell clusters and the biomarker FUT11 in ovarian cancer progression.Cancer cell international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the expression of FUT8, STX4, and calpain2 in ovarian tumor tissues and their association with clinicopathological characteristics.
methodsThis retrospective study analyzed the expression of FUT8, STX4, and calpain2 in ovarian tumor samples from patients treated at Shanghai Pudong New Area People's Hospital between January 1, 2008, and December 31, 2017. The association between marker expression and histopathological features was evaluated. Binary logistic regression was used to assess the diagnostic value of these markers in malignant ovarian tumors.
resultsThe expression of FUT8, STX4, and calpain2 was significantly higher in malignant ovarian tumors compared to benign tumors (all P < 0.05). A positive correlation was observed among the expressions of FUT8, STX4, and calpain2 (all P < 0.001). FUT8 expression was associated with the International Federation of Gynecology and Obstetrics (FIGO) stage (P = 0.013), STX4 expression was related to patient age (P = 0.012) and lymph node metastasis (P = 0.019). Patients with high co-expression of all three markers had a significantly higher likelihood of having malignant ovarian tumors compared to those with low expression of at least one marker (P = 0.002).
conclusionsSimultaneous detection of FUT8, STX4, and calpain2 expression in ovarian tumor tissues provides valuable diagnostic insights for malignant ovarian tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.